Impax Labs slumps as JPMorgan lowers rating
Shares of Impax Laboratories Inc. skidded Wednesday after a JPMorgan analyst lowered his rating on the generic drugmaker, saying its most promising products won't be on the market for another year and a half to two years.
Read more on AP via Yahoo! Malaysia
订阅:
博文评论 (Atom)
没有评论:
发表评论